Your browser doesn't support javascript.
loading
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer.
Zhang, Yi; Tacheva-Grigorova, Silvia K; Sutton, Janette; Melton, Zea; Mak, Yvonne S L; Lay, Cecilia; Smith, Bryan A; Sai, Tao; Van Blarcom, Thomas; Sasu, Barbra J; Panowski, Siler H.
Afiliação
  • Zhang Y; Allogene Therapeutics, South San Francisco, California.
  • Tacheva-Grigorova SK; Allogene Therapeutics, South San Francisco, California.
  • Sutton J; Allogene Therapeutics, South San Francisco, California.
  • Melton Z; Allogene Therapeutics, South San Francisco, California.
  • Mak YSL; Allogene Therapeutics, South San Francisco, California.
  • Lay C; Allogene Therapeutics, South San Francisco, California.
  • Smith BA; Allogene Therapeutics, South San Francisco, California.
  • Sai T; Pfizer Worldwide Research and Development, South San Francisco, California.
  • Van Blarcom T; Allogene Therapeutics, South San Francisco, California.
  • Sasu BJ; Allogene Therapeutics, South San Francisco, California.
  • Panowski SH; Allogene Therapeutics, South San Francisco, California.
Clin Cancer Res ; 29(5): 971-985, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36692420

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article